Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
Source:
Nasdaq GlobeNewswire
/
26 Dec 2023 16:01:00 America/New_York
N/A
Share on,